Last updated on August 2018

Propafenone Versus Amiodarone in Septic Shock


Brief description of study

Arrhythmias accompany septic shock in increased rates than in other ICU cohorts and their presence and management are related to patients prognosis. 1c class antiarrhythmics are seldom administered in intensive care due to a dose dependent toxicity published in case reports and unfavourable outcome reported in a few prospective trials done on cardiology patients. The papers on 1c class antiarrhythmics do not take into consideration a complex haemodynamic assessment using echocardiography. The authors have recently presented a retrospective study on SV arrhythmias in septic shock patients demonstrating favourable effect and safety of propafenone which showed higher antiarrhythmic efficacy than amiodarone.

Detailed Study Description

Primary aim is to verify the conclusions of the retrospective study, i.e. efficacy and safety of propafenone, in a prospective blinded randomized trial performed in two large intensive care units. Secondary aims are to monitor the electromechanics of left atrium in patients with SV arrhythmias in septic shock.

Clinical Study Identifier: NCT03029169

Contact Investigators or Research Sites near you

Start Over

Martin Balik, MD, PhD

Dept of Anaesthesia and Intensive Care, General University Hospital, 1st Medical Faculty, Charles University
Prague 2, Czechia
  Connect »

Petr Waldauf, MD

Dept. Anaesthesia and Intensive Care, 3rd Medical Faculty, Charles University
Prague 10, Czechia
  Connect »